β-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis

Molecular Pharmacology

Volumn 67, Issue 4, 2005, Pages 1229-1236

  Hunton, Dacia L ^a   Barnes, William G ^a   Kim, Jihee ^a   Ren, Xiu Rong ^a   Violin, Jonathan D ^a   Reiter, Eric ^a   Milligan, Graeme ^b   Patel, Dhavalkumar D ^c   Lefkowitz, Robert J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II DERIVATIVE; BETA ARRESTIN; CHEMOKINE; EPIDERMAL GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; SMALL INTERFERING RNA;

ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ARRESTINS; CELLS, CULTURED; CHEMOTAXIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GTP-BINDING PROTEINS; HUMANS; LYSOPHOSPHOLIPIDS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERTUSSIS TOXIN; PROTEIN KINASE C; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, SMALL INTERFERING;

EID: 15744390934     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.006270     Document Type: Article

References (59)

1. Ahn S, Nelson CD, Garrison TR, Miller WE, and Lefkowitz RJ (2003) Desensitization, internalization and signaling functions of β-arrestins demonstrated by RNA interference. Proc Natl Acad Sci USA 100:1740-1744.
2. Ahn S, Shenoy SK, Wei H, and Lefkowitz RJ (2004a) Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J Biol Chem 279:35518-35525.
3. Ahn S, Wei H, Garrison TR, and Lefkowitz RJ (2004b) Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2. J Biol Chem 279:7807-7811.
4. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, Snyder SH, Caron MG, and Lefkowitz RJ (1992) Beta-arrestin 2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 267:17882-17890.
5. Bailly M, Wyckoff J, Bouzahzah B, Hammerman R, Sylvestre V, Cammer M, Pestell R, and Segall JE (2000) Epidermal growth factor receptor distribution during chemotactic responses. Mol Biol Cell 11:3873-3883.
6. αq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem, in press. DOI: 10.1074/jbc.M412924200.
7. Bayes-Genis A, Conover CA, and Schwartz RS (2000) The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86:125-130.
8. Bennett NT and Schultz GS (1993) Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 165:728-737.
9. Berk BC (2001) Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 81:999-1030.
10. Bhattacharya M, Anborgh PH, Babwah AV, Dale LB, Dobransky T, Benovic JL, Feldman RD, Verdi JM, Rylett RJ, and Ferguson SS (2002) beta-Arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol 4:547-555.
11. Bredin CG, Liu Z, Hauzenberger D, and Klominek J (1999) Growth-factor-dependent migration of human lung-cancer cells. Int J Cancer 82:338-345.
12. Caric D, Raphael H, Viti J, Feathers A, Wancio D, and Lillien L (2001) EGFRs mediate chemotactic migration in the developing telencephalon. Development 128: 4203-4216.
13. Claing A, Chen W, Miller WE, Vitale N, Moss J, Premont RT, and Lefkowitz RJ (2001) β-Arrestin-mediated ADP-ribosylation factor 6 activation and β2-adrenergic receptor endocytosis. J Biol Chem 276:42509-42513.
14. Clunn GF, Refson JS, Lymn JS, and Hughes AD (1997) Platelet-derived growth factor beta-receptors can both promote and inhibit chemotaxis in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:2622-2629.
15. Cospedal R, Abedi H, and Zachary I (1999) Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases. Cardiovasc Res 41:708-721.
16. de Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472.
17. Devreotes P and Janetopoulos C (2003) Eukaryotic chemotaxis: distinctions between directional sensing and polarization. J Biol Chem 278:20445-20448.
18. 2+ and the involvement of cyclic GMP. Br J Pharmacol 121:643-648.
19. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, and Patel DD (2002) Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci USA 99:7478-7483.
20. Ge L, Ly Y, Hollenberg M, and DeFea K (2003) A β-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J Biol Chem 278:34418-34426.
21. Gerrard JM, Clawson CC, and White JG (1980) Lysophosphatidic acids: III. Enhancement of neutrophil chemotaxis. Am J Pathol 100:609-618.
22. 3 integrin expression in rat neonatal cardiac fibroblasts. Hypertension 35:978-984.
23. Hansen JL, Theilade J, Haunso S, and Sheikh SP (2004) Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits galphaq protein signaling but not ERK activation. J Biol Chem 279:24108-24115.
24. Hines J, Fluharty SJ, and Yee DK (2003) Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways. Biochem Pharmacol 66:251-262.
25. Holloway AC, Qian H, Pipolo L, Ziogas J, Miura S, Karnik S, Southwell BR, Lew MJ, and Thomas WG (2002) Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization and phosphorylation of type 1A angiotensin receptors. Mol Pharmacol 61:768-777.
26. Limatola C, Di Bartolomeo S, Trettel F, Lauro C, Ciotti MT, Mercanti D, Castellani L, and Eusebi F (2003) Expression of AMPA-type glutamate receptors in HEK cells and cerebellar granule neurons impairs CXCL2-mediated chemotaxis. J Neuroimmunol 134:61-71.
27. 2+ in rat portal vein myocytes. J Biol Chem 272:10095-10102.
28. Maghazachi AA (2003) G protein-coupled receptors in natural killer cells. J Leukoc Biol 74:16-24.
29. Masuda K, Yokomizo T, Izumi T, and Shimizu T (1999) cDNA cloning and characterization of guinea-pig leukotriene B4 receptor. Biochem J 342:79-85.
30. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, and Lefkowitz RJ (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science (Wash DC) 290:1574-1577.
31. McDonald PH and Lefkowitz RJ (2001) Beta-Arrestins: new roles in regulating heptahelical receptors' functions. Cell Signal 13:683-689.
32. Meloche S, Landry J, Huot J, Houle F, Marceau F, and Giasson E (2000) p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle. Am J Physiol 279:H741-H751.
33. Nadal JA, Scicli GM, Carbini LA, and Scicli AG (2002) Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB. Am J Physiol 282:H739-H748.
34. Neptune ER, Iiri T, and Bourne HR (1999) Gai is not required for chemotaxis mediated by Gi-coupled receptors. J Biol Chem 274:2824-2828.
35. Ni W, Kitamoto S, Ishibashi M, Usui M, Inoue S, Hiasa K, Zhao Q, Nishida K, Takeshita A, and Egashira K (2004) Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24:534-539.
36. Phillips MI and Kagiyama S (2002) Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 3:569-577.
37. Puglianiello A, Germani D, Rossi P, and Cianfarani S (2000) IGF-I stimulates chemotaxis of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, phosphatidylinositol-3 kinase pathway and plasmin system. J Endocrinol 165:123-131.
38. Riaz AA, Wang Y, Schramm R, Sato T, Menger MD, Jeppsson B, and Thorlacius H (2004) Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J 18:881-883.
39. Roland J, Murphy BJ, Ahr B, Robert-Hebmann V, Delauzun V, Nye KE, Devaux C, and Biard-Piechaczyk M (2003) Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood 101:399-406.
40. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, and Egido J (2001) Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38:1382-1387.
41. Sadoshima J (1998) Versatility of the angiotensin II type 1 receptor. Circ Res 82:1352-1355.
42. 1 receptor-independent functions of losartan. Circ Res 90:754-756.
43. Schenk PW, Epskamp SJ, Knetsch ML, Harten V, Lagendijk EL, van Duijn B, and Snaar-Jagalska BE (2001) Lysophosphatidic acid- and Gbeta-dependent activation of Dictyostelium MAP kinase ERK2. Biochem Biophys Res Commun 282:765-772.
44. Seta K, Nanamori M, Modrall JG, Neubig RR, and Sadoshima J (2002) AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J Biol Chem 277:9268-9277.
45. Stahle M, Veit C, Bachfischer U, Schierling K, Skripczynski B, Hall A, Gierschik P, and Giehl K (2003) Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J Cell Sci 116:3835-3846.
46. Su SB, Gong W, Gao JL, Shen W, Murphy PM, Oppenheim JJ, and Wang JM (1999) A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 189:395-402.
47. Sun Y, Cheng Z, Ma L, and Pei G (2002) Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 277:49212-49219.
48. Suzuki Y, Ruiz-Ortega M, and Egido J (2000) Angiotensin II: a double-edged sword in inflammation. J Nephrol 13 (Suppl 3):S101-S110.
49. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, and Egido J (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35:881-900.
50. 1A) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state. J Biol Chem 275:2893-2900.
51. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, Oakley RH, Caron MG, Lefkowitz RJ, and Luttrell LM (2003) The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278:6258-6267.
52. Touyz RM and Schiffrin EL (2000) Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52:639-672.
53. Ueda H, Siani MA, Gong W, Thompson DA, Brown GG, and Wang JM (1997) Chemically synthesized SDF-1α analogue, N33A, is a potent chemotactic agent for CXCR4/Fusin/LESTR-expressing human leukocytes. J Biol Chem 272:24966-24970.
54. Ushio-Fukai M, Alexander RW, Akers M, Lyons PR, Lassegue B, and Griendling KK (1999) Angiotensin II receptor coupling to phospholipase D is mediated by the βγ subunits of heterotrimeric G proteins in vascular smooth muscle cells. Mol Pharmacol 55:142-149.
55. Walker JK, Fong AM, Lawson BL, Savov JD, Patel DD, Schwartz DA, and Lefkowitz RJ (2003) Beta-arrestin-2 regulates the development of allergic asthma. J Clin Investig 112:566-574.
56. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, and Lefkowitz RJ (2003) Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100:10782-10787.
57. Weinstock JV, Blum AM, and Kassab JT (1987) Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni. Cell Immunol 107:180-187.
58. Xi XP, Graf K, Goetze S, Fleck E, Hsueh WA, and Law RE (1999) Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:73-82.
59. Zhao M, Pu J, Forrester JV, and McCaig CD (2002) Membrane lipids, EGF receptors and intracellular signals colocalize and are polarized in epithelial cells moving directionally in a physiological electric field. FASEB J 16:857-859.